Objective: To investigate the changes and clinical significance of serum sex hormone-binding globulin(SHBG) in patients with different ovarian responses during controlled ovarian hyperstimulation(COH).Methods: A total of 378 women, including 83 with poor ovarian response(POR), 204 with normal response, and 91 with high ovarian response(HOR), were selected for in vitro fertilization(IVF) with gonadotropin-releasing hormone antagonist(GnRH-ant) in the reproductive center of our hospital from January 2018 to January 2020. Serum samples were collected from each participant every 2-3 days during the COH cycle to measure serum SHBG, follicle stimulating hormone(FSH), luteinizing hormone(LH), estradiol(E2). Results: Compared with the normal response group, the baseline value of serum SHBG in POR group and the serum SHBG level on the day of human chorionic gonadotropin(HCG) injection decreased significantly(P<0.05), whereas the level of serum SHBG in the HOR group was significantly higher(P<0.05). By multivariate Logistic regression analysis, the serum SHBG level on the day of HCG injection was correlated with the occurrence of POR or HOR(P<0.05). During COH, the serum SHBG level decreased overall(P<0.001). Serum E2 concentration and number of dominant follicles(diameter>10 mm) were significantly increased, while serum LH level was decreased(P<0.001). There was no significant difference in the change trend of different ovarian response groups(P>0.05). The serum level of SHBG on the day of HCG injection was positively correlated with oocyte count, effective embryo count, serum level of E2 and serum level of LH at Day 3(D3) of GnRH-ant injection(P<0.05). According to the analysis of receiver operating characteristic curve, the AUC of serum SHBG level on the day of HCG injection on predicting POR or HOR was 0.718(95% CI 0.636-0.801) and 0.489(95% CI 0.391-0.604), respectively. Conclusion: During GnRH-ant, the serum SHBG level is positively correlated with the ovarian response, and can be used as one of the effective predictors of POR. |
[1] 熊奕雯, 张俊韦, 王璐璐, 等.探讨长效生长激素预处理对高龄助孕患者IVF/ICSI临床结局及安全性的影响[J].中华生殖与避孕杂志, 2021, 41(9):783-789.
[2] 李文澍, 包洪初, 张伟, 等.卵泡期长效长方案改善子宫内膜异位症患者IVF/ICSI的临床结局[J].中华生殖与避孕杂志, 2021, 41(6):496-502.
[3] 王紫微, 范艳丽, 辛欣, 等.FSH/LH在AMH正常人群中评估卵巢低反应的价值[J].河北医科大学学报, 2021, 42(9):1057-1062.
[4] GIANNELOU P, SIMOPOULOU M, GRIGORIADIS S, et al.The conundrum of poor ovarian response:from diagnosis to treatment[J].Diagnostics(Basel), 2020, 10(9):687-708.
[5] SCHEINHARDT M O, LERMAN T, KÖNIG I R, et al.Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF[J].Hum Reprod, 2018, 33(8):1499-1505.
[6] ZHU J L, CHEN Z, FENG W J, et al.Sex hormone-binding globulin and polycystic ovary syndrome[J].Clin Chim Acta, 2019, 499:142-148.
[7] ARATHIMOS R, MILLARD L A C, BELL J A, et al.Impact of sex hormone-binding globulin on the human phenome[J].Hum Mol Genet, 2020, 29(11):1824-1832.
[8] 邬晓琳, 李萍.激动剂长方案下促性腺激素使用时长对体外受精胚胎移植妊娠结局的影响[J].山东大学学报(医学版), 2021, 59(7):32-37.
[9] YEAP B B, KNUIMAN M W, HANDELSMAN D J, et al.A 5alpha-reductase(SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase(CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally[J].Clin Endocrinol(Oxf), 2019, 90(2):301-311.
[10] SIMÓ R, BARBOSA-DESONGLES A, LECUBE A, et al.Potential role of tumor necrosis factor-alpha in downregulating sex hormone-binding globulin[J].Diabetes, 2012, 61(2):372-382.
[11] RAMACHANDRAN S, HACKETT G I, STRANGE R C.Sex hormone binding globulin:a review of its interactions with testosterone and age, and its impact on mortality in men with type 2 diabetes[J].Sex Med Rev, 2019, 7(4):669-678.
[12] GEBHART V M, CALDWELL J D, RODEWALD A, et al.Estrogen receptors and sex hormone binding globulin in neuronal cells and tissue[J].Steroids, 2019, 142:94-99.
[13] QU X, DONNELLY R.Sex hormone-binding globulin(SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome[J].Int J Mol Sci, 2020, 21(21):8191-8207.
[14] 魏景蕊, 袁巾惠, 白晶莹, 等.评估卵巢储备功能的常用指标对预测卵巢反应性的价值比较[J].生殖医学杂志, 2020, 29(1):27-32.
[15] 乔杰, 齐新宇, 徐雅兰, 等.关注影响女性健康的重要生殖内分泌疾病多囊卵巢综合征[J].中国实用妇科与产科杂志, 2020, 36(1):1-9.
[16] 罗诗琪, 杨冬梓.高龄多囊卵巢综合征患者生育窗特点[J].中华生殖与避孕杂志, 2019, 39(6):462-466.
[17] TEEDE H, MISSO M, TASSONE E C, et al.AntiMullerian hormone in PCOS:a review informing international guidelines[J].Trends Endocrinol Metab, 2019, 30(7):467-478.
[18] KITAJIMA M, DEFRERE S, DOLMANS M M, et al.Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis[J].Fertil Steril, 2011, 96(3):685-691. |